The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Dasiglucagon* is a potential first-in-class glucagon analog for prevention and treatment of low blood sugar in type 1 diabetes using an automated pump system Dasiglucagon was dosed using the iLet(TM) ...
Beta Bionics (NASDAQ:BBNX) Chief Financial Officer Stephen Feider said the company's first-quarter outperformance was supported by increasing use of the pharmacy reimbursement channel, expanded sales ...
The US Food and Drug Administration (FDA) cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with type 1 diabetes. These two devices, ...
The Food and Drug Administration has cleared the Beta Bionics iLet ACE Pump and the iLet Dosing Decision Software for people six years of age and older with Type 1 diabetes. These two devices, along ...
The following is the third part of a series on brain-machine integration and biomechanical solutions to restore function to tissues damaged by disease, trauma, or time. The FDA recently granted ...
The new iLet Bionic Pancreas system was cleared by the FDA for patients 6 and older with type 1 diabetes, the agency announced Friday. The pocket-sized system features the the Beta Bionics iLet ACE ...
The US Food and Drug Administration (FDA) has cleared Beta Bionics's iLet ACE Pump and the iLet Dosing Decision Software for people ages 6 years and older with type 1 diabetes. Working together with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results